{"pmid":32469283,"title":"The future of cancer research after COVID-19 pandemic: recession?","text":["The future of cancer research after COVID-19 pandemic: recession?","Future Oncol","Kourie, Hampig Raphael","Eid, Roland","Haddad, Fady","Ghosn, Marwan","Sarkis, Dolla Karam","32469283"],"journal":"Future Oncol","authors":["Kourie, Hampig Raphael","Eid, Roland","Haddad, Fady","Ghosn, Marwan","Sarkis, Dolla Karam"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469283","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.2217/fon-2020-0397","keywords":["covid-19","sars-cov-2","cancer","ethics","funds","research","trials"],"weight":0,"_version_":1668420887260430336,"score":9.490897,"similar":[{"pmid":32386875,"title":"Managing Cancer Care during the COVID-19 Pandemic and Beyond.","text":["Managing Cancer Care during the COVID-19 Pandemic and Beyond.","The coronavirus disease 2019 (COVID-19) pandemic is posing insurmountable challenges to healthcare systems globally. Cancer therapy is complex, and outcomes are centered on timing. Many oncology societies and health ministries have issued guidelines for cancer care to enable oncologists and patients to navigate the crisis. Lessons learned should inform care models for future pandemics.","Trends Cancer","Alhalabi, Omar","Subbiah, Vivek","32386875"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic is posing insurmountable challenges to healthcare systems globally. Cancer therapy is complex, and outcomes are centered on timing. Many oncology societies and health ministries have issued guidelines for cancer care to enable oncologists and patients to navigate the crisis. Lessons learned should inform care models for future pandemics."],"journal":"Trends Cancer","authors":["Alhalabi, Omar","Subbiah, Vivek"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32386875","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.trecan.2020.04.005","keywords":["covid-19","cancer","chemotherapy","immunotherapy","pandemic","research"],"topics":["Prevention"],"weight":1,"_version_":1666428892600074242,"score":70.65202},{"pmid":32352594,"title":"Phytotherapic compounds against coronaviruses: possible streams for future research.","text":["Phytotherapic compounds against coronaviruses: possible streams for future research.","Recently, an epidemic disease outbreak caused by a novel human coronavirus has surged worldwide. Our aim is to briefly describe the potential help of phytotherapy research in finding new integrative therapeutic options against human coronaviruses, and to provide researchers with some essential hints to be used for planning future studies. Existing evidence mostly derives from laboratory studies, whereas clinical data have been only collected for multi-component formulations used in Traditional Chinese Medicine in addition to standard care. Herbs with anti-viral properties like Glycyrrhiza glabra, Scutellaria baicalensis, Sambucus nigra, Pelargonium sidoides, or Cistus incanus, as well as herbal remedies with immune boosting effects like Astragalus membranaceus or Echinacea purpurea may all appear interesting options to study. This article is protected by copyright. All rights reserved.","Phytother Res","Antonelli, Michele","Donelli, Davide","Maggini, Valentina","Firenzuoli, Fabio","32352594"],"abstract":["Recently, an epidemic disease outbreak caused by a novel human coronavirus has surged worldwide. Our aim is to briefly describe the potential help of phytotherapy research in finding new integrative therapeutic options against human coronaviruses, and to provide researchers with some essential hints to be used for planning future studies. Existing evidence mostly derives from laboratory studies, whereas clinical data have been only collected for multi-component formulations used in Traditional Chinese Medicine in addition to standard care. Herbs with anti-viral properties like Glycyrrhiza glabra, Scutellaria baicalensis, Sambucus nigra, Pelargonium sidoides, or Cistus incanus, as well as herbal remedies with immune boosting effects like Astragalus membranaceus or Echinacea purpurea may all appear interesting options to study. This article is protected by copyright. All rights reserved."],"journal":"Phytother Res","authors":["Antonelli, Michele","Donelli, Davide","Maggini, Valentina","Firenzuoli, Fabio"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352594","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ptr.6712","keywords":["coronavirus","covid-19","phytotherapy","research","sars","traditional chinese medicine"],"locations":["Scutellaria","Astragalus","Echinacea"],"topics":["Treatment"],"weight":1,"_version_":1666138495751553024,"score":61.62852},{"pmid":32344317,"pmcid":"PMC7174983","title":"Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.","text":["Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.","The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 complications. This observation led many oncologists to change their daily practice in cancer care, without solid evidence and recommendations. Moreover, the COVID-19 manifestations as well as its diagnosis are particular in this special population. In this review paper we expose the challenges of cancer management in the era of SARS-CoV-2, the epidemiological, clinical, pathological and radiological characteristics of the disease in cancer patients and its outcomes on this population. Finally, we focus on strategies that are followed in cancer management with review of national and international guidelines.","Crit Rev Oncol Hematol","Moujaess, Elissar","Kourie, Hampig Raphael","Ghosn, Marwan","32344317"],"abstract":["The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 complications. This observation led many oncologists to change their daily practice in cancer care, without solid evidence and recommendations. Moreover, the COVID-19 manifestations as well as its diagnosis are particular in this special population. In this review paper we expose the challenges of cancer management in the era of SARS-CoV-2, the epidemiological, clinical, pathological and radiological characteristics of the disease in cancer patients and its outcomes on this population. Finally, we focus on strategies that are followed in cancer management with review of national and international guidelines."],"journal":"Crit Rev Oncol Hematol","authors":["Moujaess, Elissar","Kourie, Hampig Raphael","Ghosn, Marwan"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344317","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.critrevonc.2020.102972","keywords":["covid-19","cancer patients","oncology","research","systematic review"],"locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis","Prevention"],"weight":1,"_version_":1666138495791398913,"score":56.27691},{"pmid":32442894,"title":"Pandemics and psychiatry: Repositioning research in context of COVID-19.","text":["Pandemics and psychiatry: Repositioning research in context of COVID-19.","The current Covid-19 pandemic is posing an unprecedented threat to global well-being and its mental health consequences are just becoming understood. While the crisis has led to a temporary halt in a lot of ongoing or planned psychiatric research, this pandemic is a natural experiment that can help the field to repurpose research to better understand the causes, presentations and outcome trajectories as well as treatments in psychiatry. Inter-disciplinary collaborations between researchers are needed to rapidly develop and share the emerging new knowledge of the mental health implications of Covid-19, This will help mount an effective response to the current as well as future pandemics.","Asian J Psychiatr","Keshavan, Matcheri S","32442894"],"abstract":["The current Covid-19 pandemic is posing an unprecedented threat to global well-being and its mental health consequences are just becoming understood. While the crisis has led to a temporary halt in a lot of ongoing or planned psychiatric research, this pandemic is a natural experiment that can help the field to repurpose research to better understand the causes, presentations and outcome trajectories as well as treatments in psychiatry. Inter-disciplinary collaborations between researchers are needed to rapidly develop and share the emerging new knowledge of the mental health implications of Covid-19, This will help mount an effective response to the current as well as future pandemics."],"journal":"Asian J Psychiatr","authors":["Keshavan, Matcheri S"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442894","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ajp.2020.102159","keywords":["covid-19","mental health","pandemics","psychiatry","research"],"weight":0,"_version_":1667535119544483840,"score":50.928535},{"pmid":32414641,"title":"The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed.","text":["The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed.","Eur J Intern Med","Lee, Paul H","32414641"],"journal":"Eur J Intern Med","authors":["Lee, Paul H"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414641","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ejim.2020.04.057","keywords":["protocol","sars-cov-2","sample size","statistics","trials"],"weight":0,"_version_":1666994545948098561,"score":50.304634}]}